Biotech Bargains: 4 Names Trading Far Below Their Average Price Targets

If you want to pick your own biotech stocks, rather than investing in a biotech-focused ETF or mutual fund, the author of today’s article advises that “one strategy is to search for value by looking for biotech stocks that trade at the steepest discount to where Wall Street analysts expect them to trade in the near term.” With that, he proceeds to highlight four biotech stocks with market values over $5 billion that are trading the farthest below their average analyst price targets. For these four undervalued biotech stocks, CLICK HERE.